Pliant Therapeutics annual operating margin
2019
2020
2021
2022
2023
Pliant Therapeutics's operating margin was −11,654.75% for fiscal 2023.
View full Pliant Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −11,654.75% | −10341.38 pp |
| 2022 | 2022-12-31 | −1,313.37% | −25.27 pp |
| 2021 | 2021-12-31 | −1,288.10% | −1188.51 pp |
| 2020 | 2020-12-31 | −99.59% | −97.43 pp |
| 2019 | 2019-12-31 | −2.16% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2023 | 2023-06-30 | −19,083.87% | −18489.72 pp |
| Q1 2023 | 2023-03-31 | −3,160.29% | −901.60 pp |
| Q4 2022 | 2022-12-31 | −1,903.31% | −672.74 pp |
| Q3 2022 | 2022-09-30 | −2,155.67% | −471.63 pp |
| Q2 2022 | 2022-06-30 | −594.15% | +686.12 pp |
| Q1 2022 | 2022-03-31 | −2,258.69% | −1204.46 pp |
| Q4 2021 | 2021-12-31 | −1,230.57% | −804.68 pp |
| Q3 2021 | 2021-09-30 | −1,684.04% | −1337.94 pp |
| Q2 2021 | 2021-06-30 | −1,280.27% | −808.71 pp |
| Q1 2021 | 2021-03-31 | −1,054.23% | −1092.27 pp |
| Q4 2020 | 2020-12-31 | −425.89% | — |
| Q3 2020 | 2020-09-30 | −346.09% | — |
| Q2 2020 | 2020-06-30 | −471.56% | — |
| Q1 2020 | 2020-03-31 | 38.04% | — |
Across the available reported history, Pliant Therapeutics's operating margin decreased from −1,313.37% to −11,654.75%, a change of −10341.38 percentage points. The latest reported quarter, Q2 2023, shows −19,083.87%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pliant Therapeutics filings at SEC.gov ↗